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Background: Anxiety in children is common and incapacitating and increases the risk of mental health disorders
in adulthood. Although effective interventions are available, few children are identified and referred for specialist
treatment. Alternative approaches in which prevention programmes are delivered in school appear promising.
However, comparatively little is known about the best intervention leader (health care–led vs. school-led), long-term
effects or the primary preventive value of such programmes.
Methods/Design: Preventing Anxiety in Children through Education in Schools, or PACES, is a pragmatic cluster
randomised controlled trial evaluating the effectiveness of a cognitive-behavioural therapy prevention programme
(FRIENDS) on symptoms of anxiety and low mood in 9- to 10-year-old children. Forty-one schools were randomly
assigned to one of three conditions: school-led FRIENDS, health care–led FRIENDS or treatment as usual. Assessments
were undertaken at baseline, 6 months and 12 months, with the primary outcome measure being the Revised Child
Anxiety and Depression Scale score at 12 months. Secondary outcome measures are changes in self-esteem, worries,
bullying and life satisfaction.
Discussion: This protocol summarises the procedure for the 24-month follow-up of this cohort. The study will
determine the medium-term effectiveness of an anxiety prevention programme delivered in schools.
Trial registration: ISRCTN23563048
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Anxiety and depressive disorders in children are common.
The investigators in the American Great Smoky Mountains
Study found that, during a 3-month period, 2.4% of chil-
dren ages 9 to 16 years fulfilled the diagnostic criteria
for an anxiety disorder and 2.2% met the criteria for a
depressive disorder [1]. Similar rates were found in the
British Mental Health Survey, in which 3.7% of 5- to
15-year-olds had a current anxiety disorder and 1%
had a depressive disorder [2]. Comorbidity of anxiety
and depression is common [3,4], with cumulative rates
suggesting that, by 16 to 17 years of age, 15% to 18% of
children will have experienced an impairing emotional
disorder of anxiety or depression [1,4].* Correspondence: p.stallard@bath.ac.uk
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unless otherwise stated.Longitudinal studies highlight that child mental health
disorders persist into adulthood. In the Dunedin birth
cohort study, approximately 52% to 55% of young adults
with depression or anxiety met the diagnostic criteria for
a mental health disorder before 15 years of age, with
75% receiving a first diagnosis before the age of 18 [5].
Childhood anxiety increases the risk of anxiety, depression,
substance misuse and educational underachievement
in early adulthood [6]. Similarly, childhood depression
increases the risk of suicide, subsequent depression and
substance misuse. The associated health-related burden
and economic and societal costs are considerable, and the
need to improve the mental health of children is being in-
creasingly recognised as a priority at the global level [7-9].
Whilst effective psychological treatments are available,
few children with emotional disorders receive them.
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children with anxiety disorders and less than one-half
with depressive disorders had sought or received help from
specialists over a 1- to 3-year period [10,11]. The persist-
ence of emotional disorders, as well as the immediate and
future burden, and the limited reach of treatment services
have led to interest in alternative approaches to improve
the mental health of children.
School-based mental illness prevention programmes
offer an attractive alternative to traditional treatment ap-
proaches. Systematic reviews have highlighted that anxiety
and depression prevention programmes can be effective,
although the results have been widely variable [12-15].
Methodologically, many of these studies are poorly de-
signed, sample sizes are small, comparisons with other
active interventions are lacking and follow-up is limited.
Implementation studies whereby efficacious interventions
are evaluated in suitably powered trials under everyday
conditions are comparatively few and have delivered disap-
pointing results. Recent evaluations of large, well-designed
depression prevention programmes delivered for children
in schools, for example, have failed to find intervention
effects [16-18]. Although the results of anxiety prevention
programmes have tended to be more encouraging, recent
implementation trials have failed to find positive effects
[19,20]. Two important issues that will influence programme
effectiveness in preventing mental health problems in
children are the ways in which the programme is pro-
vided (universally versus targeted) and who delivers the
intervention (health care professionals versus teachers)
[12,14,15].
Prevention programmes can be provided universally (that
is, to all of an identified population, regardless of risk
status) or targeted toward those at risk of developing
mental health disorders or showing early signs of a disorder
[21]. Universal programmes avoid the need for costly
screening, fit better within complex school timetables,
are less stigmatising and provide opportunities for primary
prevention. This last point is important because many
trials of prevention programmes have focused on demon-
strating evidence of treatment effects (that is, reducing
current symptom levels) rather than on preventive effects,
such as a reduction in the emergence of new cases [22].
Universal interventions tend to have a smaller effect than
targeted programmes, however, and, in times of economic
pressure, may not be considered the best use of limited
resources [23,24].
In terms of delivery, health care professionals or gradu-
ates tend to be more effective than trained school staff
in delivering depression prevention programmes [15].
Reviewers have found no difference in effectiveness be-
tween health care professionals and school staff in the
delivery of anxiety prevention programmes [12]. Direct
comparisons within prevention trials between health careprofessionals and school staff have seldom been under-
taken, however, so the most effective form of prevention
programme delivery is not known.
Of the emotional health prevention programmes that
have been developed, FRIENDS for Life has been identi-
fied as one of the more efficacious programmes [13,25].
FRIENDS is based on cognitive-behavioural therapy and
develops children’s skills to enhance emotional regulation,
coping mechanisms and thinking styles. A pragmatic
randomised controlled trial is currently underway in the
United Kingdom to compare the effectiveness of universally
delivered health care–led FRIENDS, school-led FRIENDS
and usual school provision of personal, social and health
education (PSHE) at 12 months after initiation [26]. The
purpose of the Preventing Anxiety in Children through
Education in Schools (PACES) trial is to assess the
medium-term (24 months) effects. First, differences in
emotional health between health care– and school-led
FRIENDS and usual school provision of PSHE at 24 months
will be investigated. Second, the effects of the three condi-
tions at 24 months on children with high and low levels of
anxiety at baseline will be explored.
Methods/Design
PACES is a pragmatic, three-arm, parallel cluster ran-
domised controlled trial, with school used as the unit
of allocation and individual participants being the unit
of analysis [26]. Participating children were recruited
during school year 5 (ages 9 to 10 years), and all were
eligible unless they were not attending school (for example,
due to long-term sickness or excluded from school) or did
not participate in PSHE lessons for religious or other
reasons. Parent consent and child assent were obtained
before completing the assessments.
Power calculation
The study is powered to detect a difference between the
FRIENDS programme (health care–led and school-led)
and usual school provision of PSHE. On the basis of an
intracluster correlation coefficient of 0.02, 28 pupils per
class, 90% consent and 80% retention, effect sizes in the
range of 0.28 to 0.30 standard deviations are detectable
with 80% power and 5% two-sided α and including 45 to
54 schools (that is, 1,134 to 1,360 consenting pupils). On
the basis of these assumptions, a cohort of 907 to 1,088
pupils at 12 months was required.
Randomisation
After recruitment, schools in South West England were
randomised on a 1:1:1 ratio to health care–led FRIENDS,
school-led FRIENDS or usual school provision of PSHE.
Trial arms were balanced for school size, number of
students and classes, number of mixed classes, level of edu-
cational attainment and preferred time-tabling. A statistician
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one sequence from a subset with the most desirable bal-
ance properties.
Interventions
Interventions were delivered in the academic year spanning
September 2011 to July 2012. The FRIENDS interventions
consisted of nine 60-minute weekly sessions delivered
to whole classes of children (that is, universal delivery).
Children had their own workbooks, and group leaders
had a detailed session plan specifying key learning points,
objectives and core activities for each session.
For health care–led FRIENDS, each session was led by
two trained facilitators working alongside the class teacher.
All facilitators had at least an undergraduate university
degree in a relevant discipline, an appropriate profes-
sional background and/or experience in working with
children and young people. Initial two-day training and
ongoing fortnightly supervision were provided by accredited
FRIENDS trainers.
In school-led FRIENDS, sessions were led by a trained
teacher or a member of the school staff and were supported
by two facilitators. School staff attended the same two-day
training session and were offered ongoing supervision.
For usual school provision of PSHE, children participated
in the usual PSHE sessions provided by the school. All
schools were following a UK national programme designed
to develop self-awareness, management of feelings, mo-
tivation, empathy and social skills [27]. The sessions were
planned and provided solely by the teacher and did not
involve any external input from the research team.
Twenty-four-month assessment
Recruitment strategy
The PACES cohort transitioned to secondary school in
September 2013. This cohort will be invited to participate
in the 24-month assessment according to our recruit-
ment strategy drawing upon suggestions from systematic
reviews [28].
First, opt-in reply slips and a project information sheet
with the university and PACES logos will be sent from
schools to parents of all children who participate in the
PACES study. Second, playground recruitment visits will
be undertaken at the end of the day, when parents collect
their children. These recruitment steps will allow informal
discussions about the project and an opportunity for par-
ents to allow their children to participate in the study.
Third, a range of PACES publicity materials, including the
project contact details (for example, pencils, refrigerator
magnets, stress balls and message bugs), will be handed out
to children during these visits. Fourth, a PACES Facebook
page will be established as a way of allowing parents to
contact the study team and opt to have their children
participate in the study. Fifth, a £30 financial incentivewill be offered to compensate parents and children for
their time in completing the assessments.
Consent and ethical approval
Signed parent consent and child assent are required for
participation in the 24-month assessment. The 24-month
assessment was approved by the University of Bath Re-
search Ethics Approval Committee for Health.
Outcome measures: child report
Assessments were undertaken in the original PACES
project at baseline and at 6 and 12 months by self-
completed questionnaires administered by researchers
blinded to allocation arm. The 24-month assessment will
involve the same measures that have been completed on
the three previous occasions.
The primary outcome for our long-term follow-up
is the Revised Child Anxiety and Depression 30-item
Scale (RCADS-30) score assessed at 24 months [29]. This
self-report questionnaire is used to assess anxiety and de-
pression symptoms that correspond to diagnostic criteria
published in the Diagnostic and Statistical Manual of
Mental Disorders, Fourth Edition (the DSM-IV). The
30-item scale will be used, which comprises 6 subscales
to assess social phobia, separation anxiety, obsessive-
compulsive disorder, panic disorder, generalised anxiety
disorder and major depressive disorder. Items are rated
on a four-point Likert scale. The RCADS-30 has good
internal consistency, test–retest stability and convergent
and divergent validity [30,31].
Child-reported secondary outcomes will be used to as-
sess self-worth and acceptance, worry, bullying, life satis-
faction and school concerns at 24 months. The Rosenberg
Self-Esteem Scale [32] is a ten-item, self-completed ques-
tionnaire related to overall feelings of self-worth or self-
acceptance. The items are answered on a four-point scale
ranging from strongly agree to strongly disagree. The
Rosenberg Self-Esteem Scale has demonstrated good
reliability and validity across a large number of different
sample groups, including children aged 7 to 12 years, and
is one of the most commonly used and best-known meas-
urement tools for self-esteem.
The Penn State Worry Questionnaire for Children is a
self-report questionnaire that measures the tendency
of children to engage in excessive, generalised and un-
controllable worry [33]. Items are rated on a four-point
Likert scale to assess how strongly each item applies to
the child. The original scale consists of 14 items. The
11-item version used in this trial has improved psycho-
metric properties when used with children aged 8 to
12 years [34].
The Olweus Bully/Victim Questionnaire is the most
widely used questionnaire to assess the nature and extent
of bullying amongst schoolchildren. The two global items
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the victim of bullying will be used.
Subjective well-being and satisfaction with six aspects
of life (school, appearance, family, home, friendships and
health) and overall life satisfaction are assessed using a
seven-point scale. These aspects were selected from among
the 12 domains identified as contributing to the subjective
well-being of children [35].
The School Concerns Questionnaire is a 20-item scale
assessing worries about starting secondary school [36].
Items cover organisational concerns (that is, changing
classes, remembering equipment), social concerns (that is,
making new friends, being bullied) and academic concerns
(for example, homework, being able to do the work). Each
item is rated on a ten-point scale assessing the extent of
worry.
Outcome measures: parent report
Parents will first complete the same measures they
completed at baseline and at 6 and 12 months. The Strength
and Difficulties Questionnaire is a brief, widely used be-
havioural screening questionnaire for 3- to 16-year-olds
completed by parents and teachers. It asks about 25 attri-
butes, some positive and others negative. These 25 items
cover emotional symptoms, conduct problems, hyperactiv-
ity and/or inattention, peer relationship problems and
prosocial behaviours, which, added together, generate a
total difficulties score [37,38].
Second, parents will complete the parent version of
the Revised Child Anxiety and Depression 30-item Scale
(RCADS-30-P). This scale covers the same 30 items com-
pleted by the children. The RCADS-P has high internal
consistency, good test–retest reliability and good conver-
gent and divergent validity [39].
Outcome measures: economic
All children will complete the self-report Child Health
Utility–9D (CHU-9D) at 24 months [40]. The CHU-9D
has been developed specifically for children ages 7 to
11 years and is a validated measure covering nine different
domains of health-related quality of life.
A subgroup of parents (n = 307) was interviewed at
baseline and at 6 months (n = 284) using the Client Receipt
of Service Questionnaire to assess health, social care and
educational service use [41]. Parents in this subgroup who
opt to participate in the 24-month assessment will be
asked to complete this questionnaire again, along with
the assessment of life events and a screen of parent phys-
ical and mental health that they previously completed.
Statistical analysis
Data analysis will be undertaken by study members blinded
to allocation arm. Analysis and presentation of data
will be in accordance with the Consolidated Standardsof Reporting Trials (CONSORT) guidelines, in particular
with the extension to cluster randomised trials [42]. The
primary comparative analyses will be conducted on an
intention-to-treat (ITT) basis with due emphasis placed
on confidence intervals for the between-arm comparisons.
We will use descriptive statistics to assess balance
between trial arms at baseline. The primary outcome will
be assessed by ITT without imputation. To take appropri-
ate account of the hierarchical nature of the data, we will
use multivariable mixed-effects regression to compare
mean RCADS-30 scores at 24 months for health care–led
FRIENDS versus school-led FRIENDS versus usual school
provision of PSHE, with adjustments made for baseline
RCADS-30 scores and randomisation variables. These
analyses will be repeated for secondary outcomes. We
will undertake a secondary analysis using interaction
terms in the regression model to explore differences at
24 months between randomised arms and the baseline
variable (RCADS scores of 0 to 38 (low anxiety) and 39
and higher (high anxiety)).
Discussion
Adequately powered randomised trials assessing the ef-
fectiveness of anxiety prevention programmes, when im-
plemented under everyday conditions, are required before
the widespread use of these programmes can be advo-
cated. Our study will compare an efficacious programme
(FRIENDS) delivered by health care professionals or school
staff against usual school provision of PSHE. The study
will assess the effect of intervention leaders and the impact
of the programme on both high- and low-symptom chil-
dren to determine both reduction in symptomatology
and whether the intervention has a preventive effect on
low-symptom children. The 24-month assessment will allow
the medium-term effects to be determined.
Study status
Forty-one schools consented to participate in PACES and
were randomised, and one withdrew before baseline assess-
ments were undertaken. The remaining 40 schools had
1,448 eligible participants of whom 1,362 (94%) consented
to participate in the study. Twelve-month outcome data
were obtained from 1,257 consenting children (94%), result-
ing in a larger cohort than initially predicted.
Recruitment for the 24-month assessment started in
June 2013. Assessments started in October 2013 and are
scheduled to be completed by May 2014.
Abbreviations
CHU-9D: Child Health Utility Index; CONSORT: Consolidated Standards of
Reporting Trials; ITT: Intention to treat; PACES: Preventing Anxiety in Children
through Education in Schools; RCADS: Revised Child Anxiety and Depression
Scale.
Competing interests
The authors declare that they have no competing interests.
Stallard et al. Trials 2014, 15:77 Page 5 of 6
http://www.trialsjournal.com/content/15/1/77Authors’ contributions
PS, GT RA, NS, HD and RP conceived the study and led the bid to secure
funding for this work. They have contributed to the development of the
protocol and are involved in managing and advising on the project. ES is
the trial manager and has contributed to the development of the protocol
and the drafting of this paper. All authors read and approved the final
manuscript.
Acknowledgements
The project is funded by the NIHR Public Health Research Programme
(09/3000/03). The views and opinions expressed in this paper are those of the
authors and do not necessarily reflect those of the Department of Health. We
thank the members of the TSC for their oversight and support Professor Alan
Emond (Chair), Dr Cathy Creswell, Dr Richard Meiser-Stedman, Ms Pauline
Rodger and Ms Lucie Pring. We would also like to thank the DMEC, Dr Tamsin
Ford (Chair), Dr Obioha Ukoumunne and Dr Emma McIntosh.
Author details
1Department for Health, University of Bath, 22-23 Eastwood, Bath BA2 7AY, UK.
2University of Exeter Medical School, The Veysey Building, Salmon Pool Lane,
Exeter EX2 4SG, UK. 3Department of Education, University of Oxford, 15 Norham
Gardens, Oxford OX2 6PY, UK. 4Sirona Care and Health, Headquarters building,
Bath BA2 5RP, UK. 5Wales School for Primary Care Research, Cardiff University
School of Medicine, Heath Park, Cardiff CF14 4XN, UK.
Received: 6 November 2013 Accepted: 11 February 2014
Published: 13 March 2014
References
1. Costello EJ, Mustillo S, ErkanIi A, Keeler G, Angold A: Prevalence and
development of psychiatric disorders in childhood and adolescence.
Arch Gen Psychiatry 2003, 60:837–844.
2. Ford T, Goodman R, Meltzer H: The British Child and Adolescent Mental
Health Survey 1999: the prevalence of DSM-IV disorders. J Am Acad Child
Adolesc Psychiatry 2003, 42:1203–1211.
3. Garber J, Weersing VR: Comorbidity of anxiety and depression in youth:
implications for treatment and prevention. Clin Psychol (New York) 2010,
17:293–306.
4. Essau CA, Conradt J, Petermann F: Frequency, comorbidity, and
psychological impairment of anxiety disorders in German adolescents.
J Anxiety Disord 2000, 14:263–279.
5. Kim-Cohen J, Caspi A, Moffitt TE, Harrington H, Milne BJ, Poulton R: Prior
juvenile diagnoses in adults with mental disorder: developmental
follow-back of a prospective-longitudinal cohort. Arch Gen Psychiatry
2003, 60:709–717.
6. Woodward LJ, Fergusson DM: Life course outcomes of young people with
anxiety disorders in adolescence. J Am Acad Child Adolesc Psychiatry 2001,
40:1086–1093.
7. Kieling C, Baker-Henningham H, Belfer M, Conti G, Ertem I, Omigbodun O,
Rohde LA, Srinath S, Ulkuer N, Rahman A: Child and adolescent mental
health worldwide: evidence for action. Lancet 2011, 378:1515–1525.
8. Collins PY, Patel V, Joestl SS, March D, Insel TR, Daar AS, Bordin IA, Costello EJ,
Durkin M, Fairburn C, Glass RI, Hall W, Huang Y, Hyman SE, Jamison K, Kaava S,
Kapur S, Kleinman A, Ogunniyi A, Otero-Ojeda A, Poo MM, Ravindranath V,
Sahakian BJ, Saxena S, Singer PA, Stein DJ, Anderson W, Dhansay MA, Ewart W,
Phillips A, et al: for the Scientific Advisory Board and the Executive Committee
of the Grand Challenges on Global Mental Health: Grand challenges in
global mental health. Nature 2011, 475:27–30.
9. Snell T, Knapp M, Healey A, Guglani S, Evans-Lacko S, Fernandez JL, Meltzer
H, Ford T: Economic impact of childhood psychiatric disorder on public
sector services in Britain: estimates from national survey data. J Child
Psychol Psychiatry 2013, 54:977–985.
10. Ford T, Hamilton H, Meltzer H, Goodman R: Predictors of service use for
mental health problems among British schoolchildren. Child Adolesc Ment
Health 2008, 13:32–40.
11. Merikangas KR, He JP, Brody D, Fisher PW, Bourdon K, Koretz DS: Prevalence
and treatment of mental disorders among US children in the, NHANES.
Pediatrics 2001–2004, 2010(125):75–81.
12. Neil AL, Christensen H: Efficacy and effectiveness of school-based
prevention and early intervention programs for anxiety. Clin Psychol
Rev 2009, 29:208–215.13. Fisak BJ Jr, Richard D, Mann A: The prevention of child and adolescent
anxiety: a meta-analytic review. Prev Sci 2011, 12:255–268.
14. Merry SN, Hetrick SE, Cox GR, Brudevold-Iversen T, Bir JJ, McDowell H:
Psychological and educational interventions for preventing depression in
children and adolescents. Cochrane Database Syst Rev 2011, 12, CD003380.
15. Calear AL, Christensen H: Systematic review of school-based prevention
and early intervention programs for depression. J Adolesc 2010,
33:429–438.
16. Sawyer MG, Pfeiffer S, Spence SH, Bond L, Graetz B, Kay D, Patton G,
Sheffield J: School-based prevention of depression: a randomised
controlled study of the beyondblue schools research initiative. J Child
Psychol Psychiatry 2010, 51:199–209.
17. Araya R, Fritsch R, Spears M, Rojas G, Martinez V, Barroilhet S, Vöhringer P,
Gunnell D, Stallard P, Guajardo V, Gaete J, Noble S, Montgomery AA: School
intervention to improve mental health of students in Santiago, Chile: a
randomized clinical trial. JAMA Pediatr 2013, 167:1004–1010.
18. Stallard P, Sayal K, Phillips R, Taylor JA, Spears M, Anderson R, Araya R, Lewis
G, Millings A, Montgomery AA: Classroom based cognitive behavioural
therapy in reducing symptoms of depression in high risk adolescents:
pragmatic cluster randomised controlled trial. BMJ 2012, 345:e6058.
19. Miller LD, Laye-Gindhu A, Liu Y, March JS, Thordarson DS, Garland EJ:
Evaluation of a preventive intervention for child anxiety in two
randomized attention-control school trials. Behav Res Ther 2011,
49:315–323.
20. Miller LD, Laye-Gindhu A, Bennett JL, Liu Y, Gold S, March JS, Olson BF,
Waechtler VE: An effectiveness study of a culturally enriched school-based
CBT anxiety prevention program. J Clin Child Adolesc Psychol 2011,
40:618–629.
21. Mrazek PJ: Haggerty RJ (Eds.): Reducing Risks for Mental Disorders: Frontiers for
Preventive Intervention Research. Washington DC: National Academies Press;
1994.
22. Horowitz JL, Garber J: The prevention of depressive symptoms in children
and adolescents: a meta-analytic review. J Consult Clin Psychol 2006,
74:401–415.
23. Giesen F, Searle A, Sawyer M: Identifying and implementing prevention
programmes for childhood mental health problems. J Paediatr Child
Health 2007, 43:785–789.
24. Stallard P: School-based interventions for depression and anxiety in
children and adolescents. Evid Based Ment Health 2013, 16:60–61.
25. World Health Organization (WHO): Prevention of Mental Disorders. Geneva:
WHO: Effective Interventions and Policy Options; 2004. Available at
http://www.who.int/mental_health/evidence/en/
prevention_of_mental_disorders_sr.pdf (accessed 21 February 2014).
26. Stallard P, Taylor G, Anderson R, Daniels H, Simpson N, Phillips R, Skryabina
E: School-based intervention to reduce anxiety in children: study
protocol for a randomized controlled trial (PACES). Trials 2012, 13:227.
27. Department for Education and Skills: Excellence and Enjoyment: Social and
Emotional Aspects of Learning (Publication DfES 1378–2005 G). London: DFES




28. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I:
Increasing response rates to postal questionnaires: systematic review.
BMJ 2002, 324:1183.
29. Chorpita BF, Moffitt CE, Gray J: Psychometric properties of the Revised
Child Anxiety and Depression Scale in a clinical sample. Behav Res Ther
2005, 43:309–322.
30. Sandin B, Chorot P, Valiente RM, Chorpita BF: Development of a 30-item
version of the Revised Child Anxiety and Depression Scale. J
Psychopathol Clin Psychol 2010, 15:165–178. Available at http://e-spacio.
uned.es/fez/eserv.php?pid=bibliuned:Psicopat-2010-15-3-
2020&dsID=Documento.pdf (21 February 2014).
31. Muris P, Meesters C, Schouten E: A brief questionnaire of DSM-IV-defined
anxiety and depression symptoms among children. Clin Psychol
Psychother 2002, 9:430–442.
32. Rosenberg M: Society and the Adolescent Self-image. Princeton, NJ: Princeton
University Press; 1965.
33. Chorpita BF, Tracey SA, Brown TA, Collica TJ, Barlow DH: Assessment of
worry in children and adolescents: an adaptation of the Penn State
Worry Questionnaire. Behav Res Ther 1997, 35:569–581.
Stallard et al. Trials 2014, 15:77 Page 6 of 6
http://www.trialsjournal.com/content/15/1/7734. Muris P, Meesters C, Gobel M: Reliability, validity, and normative data of
the Penn State Worry Questionnaire in 8–12-yr-old children. J Behav Ther
Exp Psychiatry 2001, 32:63–72.
35. Rees G, Goswami H, Bradshaw J: Developing an Index of Children’s Subjective
Well-being in England. London: The Children’s Society; 2010. Available at
https://www.childrenssociety.org.uk/sites/default/files/tcs/research_docs/
Developing%20an%20Index%20of%20Children's%20Subjective%20Well-
being%20in%20England_0.pdf (21 February 2014).
36. Rice F, Frederickson N, Seymour J: Assessing pupil concerns about
transition to secondary school. Br J Educ Psychol 2010, 81:244–263.
37. Goodman R: The Strengths and Difficulties Questionnaire: a research
note. J Child Psychol Psychiatry 1997, 38:581–586.
38. Goodman R, Scott S: Comparing the Strengths and Difficulties
Questionnaire and the Child Behavior Checklist: Is small beautiful?
J Abnorm Child Psychol 1999, 27:17–24.
39. Ebesutani C, Chorpita BF, Higa-McMillan CK, Nakamura BJ, Regan J, Lynch
RE: A psychometric analysis of the Revised Child Anxiety and Depression
Scales–Parent Version in a school sample. J Abnorm Child Psychol 2011,
39:173–185.
40. Stevens K: Assessing the performance of a new generic measure of
health-related quality of life for children and refining it for use in health
state valuation. Appl Health Econ Health Policy 2011, 9:157–169.
41. Beecham J, Knapp M: Costing psychiatric interventions. In In Measuring
Mental Health Needs. 2nd edition. London: Gaskell: Thornicroft G; 2001:200–224.
42. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, Devereaux PJ,
Elbourne D, Egger M, Altman DG: Consolidated Standards of Reporting
Trials Group: CONSORT 2010 Explanation and Elaboration: updated
guidelines for reporting parallel group randomised trials. J Clin Epidemiol
2010, 63:e1–e37. A published erratum appears in, J Clin Epidemiol 2012,
65:351.
doi:10.1186/1745-6215-15-77
Cite this article as: Stallard et al.: The prevention of anxiety in children
through school-based interventions: study protocol for a 24-month
follow-up of the PACES project. Trials 2014 15:77.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
